Prophylactic Human Vaccine Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Prophylactic Human Vaccine
1.2 Key Market Segments
1.2.1 Prophylactic Human Vaccine Segment by Type
1.2.2 Prophylactic Human Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Prophylactic Human Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Prophylactic Human Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Prophylactic Human Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Prophylactic Human Vaccine Market Competitive Landscape
3.1 Global Prophylactic Human Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Prophylactic Human Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Prophylactic Human Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Prophylactic Human Vaccine Sales Sites, Area Served, Product Type
3.6 Prophylactic Human Vaccine Market Competitive Situation and Trends
3.6.1 Prophylactic Human Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Prophylactic Human Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Prophylactic Human Vaccine Industry Chain Analysis
4.1 Prophylactic Human Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Prophylactic Human Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Prophylactic Human Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Prophylactic Human Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Prophylactic Human Vaccine Price by Type (2019-2024)
7 Prophylactic Human Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prophylactic Human Vaccine Market Sales by Application (2019-2024)
7.3 Global Prophylactic Human Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Prophylactic Human Vaccine Sales Growth Rate by Application (2019-2024)
8 Prophylactic Human Vaccine Market Segmentation by Region
8.1 Global Prophylactic Human Vaccine Sales by Region
8.1.1 Global Prophylactic Human Vaccine Sales by Region
8.1.2 Global Prophylactic Human Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Prophylactic Human Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Prophylactic Human Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Prophylactic Human Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Prophylactic Human Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Prophylactic Human Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GSK
9.1.1 GSK Prophylactic Human Vaccine Basic Information
9.1.2 GSK Prophylactic Human Vaccine Product Overview
9.1.3 GSK Prophylactic Human Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Prophylactic Human Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Biovac
9.2.1 Biovac Prophylactic Human Vaccine Basic Information
9.2.2 Biovac Prophylactic Human Vaccine Product Overview
9.2.3 Biovac Prophylactic Human Vaccine Product Market Performance
9.2.4 Biovac Business Overview
9.2.5 Biovac Prophylactic Human Vaccine SWOT Analysis
9.2.6 Biovac Recent Developments
9.3 McKesson Medical
9.3.1 McKesson Medical Prophylactic Human Vaccine Basic Information
9.3.2 McKesson Medical Prophylactic Human Vaccine Product Overview
9.3.3 McKesson Medical Prophylactic Human Vaccine Product Market Performance
9.3.4 McKesson Medical Prophylactic Human Vaccine SWOT Analysis
9.3.5 McKesson Medical Business Overview
9.3.6 McKesson Medical Recent Developments
9.4 Merck
9.4.1 Merck Prophylactic Human Vaccine Basic Information
9.4.2 Merck Prophylactic Human Vaccine Product Overview
9.4.3 Merck Prophylactic Human Vaccine Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Recent Developments
9.5 Merial
9.5.1 Merial Prophylactic Human Vaccine Basic Information
9.5.2 Merial Prophylactic Human Vaccine Product Overview
9.5.3 Merial Prophylactic Human Vaccine Product Market Performance
9.5.4 Merial Business Overview
9.5.5 Merial Recent Developments
9.6 Zoetis
9.6.1 Zoetis Prophylactic Human Vaccine Basic Information
9.6.2 Zoetis Prophylactic Human Vaccine Product Overview
9.6.3 Zoetis Prophylactic Human Vaccine Product Market Performance
9.6.4 Zoetis Business Overview
9.6.5 Zoetis Recent Developments
9.7 Sanofi
9.7.1 Sanofi Prophylactic Human Vaccine Basic Information
9.7.2 Sanofi Prophylactic Human Vaccine Product Overview
9.7.3 Sanofi Prophylactic Human Vaccine Product Market Performance
9.7.4 Sanofi Business Overview
9.7.5 Sanofi Recent Developments
10 Prophylactic Human Vaccine Market Forecast by Region
10.1 Global Prophylactic Human Vaccine Market Size Forecast
10.2 Global Prophylactic Human Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Prophylactic Human Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Prophylactic Human Vaccine Market Size Forecast by Region
10.2.4 South America Prophylactic Human Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Prophylactic Human Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Prophylactic Human Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Prophylactic Human Vaccine by Type (2025-2030)
11.1.2 Global Prophylactic Human Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Prophylactic Human Vaccine by Type (2025-2030)
11.2 Global Prophylactic Human Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Prophylactic Human Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Prophylactic Human Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Prophylactic Human Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Prophylactic Human Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Prophylactic Human Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Prophylactic Human Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Prophylactic Human Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Human Vaccine as of 2022)
Table 10. Global Market Prophylactic Human Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Prophylactic Human Vaccine Sales Sites and Area Served
Table 12. Manufacturers Prophylactic Human Vaccine Product Type
Table 13. Global Prophylactic Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Prophylactic Human Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prophylactic Human Vaccine Market Challenges
Table 22. Global Prophylactic Human Vaccine Sales by Type (Kilotons)
Table 23. Global Prophylactic Human Vaccine Market Size by Type (M USD)
Table 24. Global Prophylactic Human Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Prophylactic Human Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Prophylactic Human Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Prophylactic Human Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Prophylactic Human Vaccine Sales (Kilotons) by Application
Table 30. Global Prophylactic Human Vaccine Market Size by Application
Table 31. Global Prophylactic Human Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Prophylactic Human Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Prophylactic Human Vaccine Market Share by Application (2019-2024)
Table 35. Global Prophylactic Human Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Prophylactic Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Prophylactic Human Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Prophylactic Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Prophylactic Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Prophylactic Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Prophylactic Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Prophylactic Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Prophylactic Human Vaccine Basic Information
Table 44. GSK Prophylactic Human Vaccine Product Overview
Table 45. GSK Prophylactic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Prophylactic Human Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Biovac Prophylactic Human Vaccine Basic Information
Table 50. Biovac Prophylactic Human Vaccine Product Overview
Table 51. Biovac Prophylactic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biovac Business Overview
Table 53. Biovac Prophylactic Human Vaccine SWOT Analysis
Table 54. Biovac Recent Developments
Table 55. McKesson Medical Prophylactic Human Vaccine Basic Information
Table 56. McKesson Medical Prophylactic Human Vaccine Product Overview
Table 57. McKesson Medical Prophylactic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. McKesson Medical Prophylactic Human Vaccine SWOT Analysis
Table 59. McKesson Medical Business Overview
Table 60. McKesson Medical Recent Developments
Table 61. Merck Prophylactic Human Vaccine Basic Information
Table 62. Merck Prophylactic Human Vaccine Product Overview
Table 63. Merck Prophylactic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Merck Business Overview
Table 65. Merck Recent Developments
Table 66. Merial Prophylactic Human Vaccine Basic Information
Table 67. Merial Prophylactic Human Vaccine Product Overview
Table 68. Merial Prophylactic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merial Business Overview
Table 70. Merial Recent Developments
Table 71. Zoetis Prophylactic Human Vaccine Basic Information
Table 72. Zoetis Prophylactic Human Vaccine Product Overview
Table 73. Zoetis Prophylactic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Zoetis Business Overview
Table 75. Zoetis Recent Developments
Table 76. Sanofi Prophylactic Human Vaccine Basic Information
Table 77. Sanofi Prophylactic Human Vaccine Product Overview
Table 78. Sanofi Prophylactic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Sanofi Business Overview
Table 80. Sanofi Recent Developments
Table 81. Global Prophylactic Human Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 82. Global Prophylactic Human Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 84. North America Prophylactic Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 86. Europe Prophylactic Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Prophylactic Human Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 88. Asia Pacific Prophylactic Human Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 90. South America Prophylactic Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Prophylactic Human Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Prophylactic Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Prophylactic Human Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 94. Global Prophylactic Human Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Prophylactic Human Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 96. Global Prophylactic Human Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 97. Global Prophylactic Human Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Prophylactic Human Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prophylactic Human Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Prophylactic Human Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Prophylactic Human Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prophylactic Human Vaccine Market Size by Country (M USD)
Figure 11. Prophylactic Human Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Prophylactic Human Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Prophylactic Human Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Prophylactic Human Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Prophylactic Human Vaccine Market Share by Type
Figure 18. Sales Market Share of Prophylactic Human Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Prophylactic Human Vaccine by Type in 2023
Figure 20. Market Size Share of Prophylactic Human Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Prophylactic Human Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Prophylactic Human Vaccine Market Share by Application
Figure 24. Global Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Prophylactic Human Vaccine Sales Market Share by Application in 2023
Figure 26. Global Prophylactic Human Vaccine Market Share by Application (2019-2024)
Figure 27. Global Prophylactic Human Vaccine Market Share by Application in 2023
Figure 28. Global Prophylactic Human Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Prophylactic Human Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Prophylactic Human Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Prophylactic Human Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Prophylactic Human Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Region in 2023
Figure 44. China Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Prophylactic Human Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Prophylactic Human Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Prophylactic Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Prophylactic Human Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Prophylactic Human Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Prophylactic Human Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Prophylactic Human Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Prophylactic Human Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Prophylactic Human Vaccine Market Share Forecast by Application (2025-2030)
Industry Market Size
